Physician profile
Christopher L Miller
NPI 1477528990
$13,829.01
in general payments reported to CMS, 2019-2025
63 companies · $1,574 in 2025
The $1,574 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,134 · 2020: $1,600 · 2021: $2,017 · 2022: $2,321 · 2023: $1,995 · 2024: $2,189 · 2025: $1,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,757.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,194.03 | 2019-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $1,101.42 | 2019-2025 | Repatha, Evenity, Repatha |
| Novo Nordisk INC | $1,033.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $864.82 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $847.48 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $672.75 | 2019-2024 | Xarelto |
| Gilead Sciences, INC. | $610.71 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $590.60 | 2019-2024 | |
| Lilly USA, LLC | $547.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $544.98 | 2019-2025 | Verquvo, Belsomra, Delstrigo |
| Smith+Nephew, INC. | $536.93 | 2019-2025 | Collagenase Santyl, Regranex |
| Pfizer INC. | $534.65 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $502.16 | 2022-2024 | |
| Amarin Pharma, INC. | $468.64 | 2019-2023 | |
| Abbott Laboratories | $363.06 | 2023-2025 | Freestyle Libre 3 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.99 | 2019-2024 | Jardiance, Tradjenta |
| Phathom Pharmaceuticals, INC. | $295.14 | 2024 | Voquezna |
| Kerecis Limited | $216.46 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| E.R. Squibb & Sons, L.L.C. | $171.11 | 2019-2024 | Eliquis |
| Esperion Therapeutics, INC. | $165.03 | 2020-2025 | Nexletol |
| Averitas Pharma INC. | $164.71 | 2023-2025 | Qutenza |
| Eisai INC. | $162.31 | 2020-2025 | |
| Organogenesis INC. | $152.32 | 2022-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.27 | 2019-2025 | Xifaxan, Trulance |
| Dexcom, INC. | $111.36 | 2022-2024 | Dexcom G6 Transmitter |
| Solventum Corporation | $110.70 | 2024-2025 | Activ.A.C., Prevena, 3m Cavilon |
| Biohaven Pharmaceutical Holding Company Ltd. | $109.61 | 2022 | |
| Theratechnologies INC. | $91.70 | 2019-2025 | Egrifta, Trogarzo |
| Urgo Medical North America, LLC | $85.81 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Allergan, INC. | $85.26 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.51 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $83.28 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $73.83 | 2019-2022 | |
| Mimedx Group, INC. | $67.30 | 2024 | |
| Grifols USA, LLC | $65.83 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $61.54 | 2024-2025 | Ingrezza |
| W. L. Gore & Associates, INC. | $47.88 | 2019-2020 | |
| Exact Sciences Corporation | $45.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Melinta Therapeutics, LLC | $37.60 | 2019 | |
| Daiichi Sankyo INC. | $35.74 | 2024-2025 | Injectafer |
| Medtronic, INC. | $34.12 | 2025 | Symplicity G3 |
| Sanofi-Aventis U.S. LLC | $33.83 | 2021 | |
| Bard Peripheral Vascular, INC. | $32.83 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $29.23 | 2023 | Rebyota |
| Inspire Medical Systems, INC. | $23.65 | 2025 | Inspire |
| Corium, LLC | $23.42 | 2023 | Azstarys |
| Sanofi Pasteur INC. | $21.86 | 2025 | |
| Viiv Healthcare Company | $20.28 | 2021 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Bsn Medical INC | $18.86 | 2022 | |
| Ossur Americas, INC. | $18.14 | 2024 | |
| Tetraphase Pharmaceuticals, INC. | $18.04 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.79 | 2025 | Austedo Xr |
| Corcept Therapeutics | $16.74 | 2025 | Korlym |
| Shionogi INC | $16.10 | 2025 | Fetroja |
| Bioventus LLC | $15.80 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.63 | 2025 | Rexulti |
| Seqirus USA INC | $14.52 | 2025 | Flucelvax |
| Misonix INC | $13.45 | 2019 | |
| Integra Lifesciences Corporation | $13.07 | 2020 | |
| Medtronic Minimed, INC. | $12.94 | 2019 | |
| Molnlycke Health Care US, LLC | $11.56 | 2025 | Mepilex Border Flex, Mepilex Transfer Ag, Tubigrip |
| Axsome Therapeutics, INC. | $8.90 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.